Myriam Giancarli: leader in the African pharmaceutical industry and a figure of health sovereignty

Myriam Giancarli, CEO of Pharma 5, at the heart of the African pharmaceutical strategy

In the era of globalization of healthcare value chains, pharmaceutical sovereignty in Africa has become a major strategic issue. In this context, Myriam Giancarli , a Moroccan executive and CEO of Pharma 5 , has emerged as a key figure in the African pharmaceutical industry, driven by a vision that combines local drug production , healthcare autonomy , and regional influence .

Myriam Giancarli's career path: international training and strategic return to Morocco

Born in Morocco to a Moroccan father and an Austrian mother, Myriam Giancarli benefits from a dual European and African cultural heritage. A graduate of Sciences Po Paris and Paris-Dauphine University , she began her career in the luxury sector, within the LVMH group, where she trained in international standards , global brand management and emerging markets .

In 2012, she chose to return to Morocco to take over the management of Pharma 5, a pharmaceutical laboratory founded in 1985. This return marked a strategic turning point, both for the company and for the Moroccan pharmaceutical ecosystem.

Pharma 5: a Moroccan pharmaceutical laboratory that has become a continental player

Under the leadership of Myriam Giancarli, Pharma 5 is evolving from a national champion in generic drugs to a leading African pharmaceutical player . The company is investing heavily in:

• the local manufacturing of generic drugs ,
• compliance with international pharmaceutical standards ,
• exporting to African and emerging markets .

Today, Pharma 5 exports its medicines to more than 40 countries , reinforcing Morocco's position as an African pharmaceutical hub and strategic supplier of essential medicines.

Pharmaceutical sovereignty and African health autonomy

For Myriam Giancarli, the pharmaceutical industry goes beyond the economic sphere. It constitutes a lever of health sovereignty , a tool of national security and a pillar of the resilience of African health systems .

His commitment to "Made in Morocco" pharmaceuticals is part of a strategy of:

• reducing dependence on foreign multinationals ,
• securing access to essential medicines ,
• South-South cooperation in health .

She advocates for the harmonization of African regulations, the creation of local industrial capacities and the development of African health diplomacy .

A discreet influence in the geopolitics of health

Despite maintaining a low media profile, Myriam Giancarli wields increasing influence in industrial and institutional circles. Considered a private sector player aligned with Morocco's industrial strategy , she actively participates in African economic forums , health summits , and discussions on the future of pharmaceutical production in Africa .

Through her leadership , she embodies a new generation of African leaders for whom the pharmaceutical industry , public health and geopolitics are inseparable.